Celldex Therapeutics
CLDX
CLDX
45 hedge funds and large institutions have $7.15M invested in Celldex Therapeutics in 2020 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
6% less funds holding
Funds holding: 48 → 45 (-3)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
24% less capital invested
Capital invested by funds: $9.42M → $7.15M (-$2.26M)
Holders
45
Holding in Top 10
1
Calls
$220K
Puts
$57K
Top Buyers
| 1 | +$91K | |
| 2 | +$84K | |
| 3 | +$58K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$36.2K |
| 5 |
MCP
Mirador Capital Partners
Pleasanton,
California
|
+$27K |
Top Sellers
| 1 | -$796K | |
| 2 | -$88K | |
| 3 | -$56K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$48K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$47.3K |